Skip to Content

Cefotaxime Injection

Last Updated: March 7, 2018
Status: Current

Cefotaxime Injection

Products Affected - Description
  • Cefotaxime Sodium powder for solution for injection, West-Ward
    1 gram, vial, 25 count (NDC 00143-9931-25)
    2 gram vial, 25 count (NDC 00143-9933-25)
    10 gram, vial, 1 count (NDC 00143-9935-01)
    500 mg vial, 10 count (NDC 00143-9930-10)
Reason for the Shortage
    • Hospira has discontinued Claforan. Sanofi-Aventis manufactured Claforan for Hospira and is no longer making the product.
    • Baxter discontinued Claforan in late-2015.
    • West-Ward has cefotaxime on shortage due to manufacturing and issues with raw material.
Available Products
  • There are no presentations available

Estimated Resupply Dates

  • West-Ward has cefotaxime 500 mg, 1 gram, 2 gram, and 10 gram vials on long-term back order and the company cannot estimate a release date.

Updated

March 7, January 2, 2018; November 10, September 26, August 29, June 25, May 15, April 11, January 24, 2017; November 6, October 8, August 31, July 19, June 21, May 17 and 5, March 23, February 16 and 1, January 26 and 6, 2016; November 30, 17, 11 and 3, October 19, September 23, August 24 and 4, June 10, April 30 and 2, January 23, 2015; December 5, October 7, September 3, June 24, April 15, February 25, January 14, 2014; December 10, October 30, August 29 and 1, July 31, 2013, University of Utah, Drug Information Service. Copyright 2018, Drug Information Service, University of Utah, Salt Lake City, UT.

Hide